Karolina Sulek

Post-doctoral Fellow

Liggins Institute & School of Biological Sciences, University of Auckland

Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it



  • Analytical chemistry
  • LCMS and GCMS based metabolomics
  • Human and animal metabolic abnormalities
  • Biomarkers discovery
  • Multivariate analysis
  • Statistics



  • 2009-2012 - PhD, Technical University of Denmark, Denmark
    • Title of the project: Bacterial Impact on the Gut Metabolome
  • 2011 External research, Metabolomics Applied to Industrial and Medical Microbiology
  • University of Auckland, New Zealand
    • Focus on: Metabolite extraction from animal samples
    • Additional work: Secondary fungal metabolites
  • 2003-2008 - Master of Science in Engineering, Warsaw University of Technology, Poland
    • Specialization: Biotechnology
  • 2007-2008 - Aalborg University (Socrates-Erasmus Student Mobility Program), Denmark
    • Student project: Ammonia removal by bio-filtration



I work in a collaborative project between Prof. Phillip Baker (Liggins Institute) and Villas-Boas lab. Our aim is to develop screening tests for major pregnancy complications: preeclampsia, preterm birth and fetal growth restriction. These complications are responsible for massive maternal and fetal complications, and surviving babies are at increased risk of serious diseases in adulthood: such as heart disease, hypertension and diabetes. In addition, we are interested in developing methods to study environmental exposures in pregnancy, and to study whether effects of treatments in pregnancy lead to changes in the metabolomic profile which suggest likely efficacy. My position of post-doctoral fellow at the University of Auckland involves development of mass spectrometry methods for metabolite profiling of biological fluids: serum, plasma and urine.




  • Sulek, K.; Frandsen, H.L.; Smedsgaard, J.; Skov, T.H.; Wilcks, A.; Licht, T.R. (2012); Metabolic footprint of Lactobacillus acidophilus NCFM at different pH; Metabolomics, 8, 2:244-252; DOI: 10.1007/s11306-011-0305-4
  • Vigsnaes, L.K. and van den Abbeele, P.; Sulek, K.; Frandsen, H.L.; Steenholdt, C.; Brynskov, J.; van de Wiele, T.; Licht, T.R. (2013); Microbiotas from UC patients display altered metabolism and a reduced ability of LAB to colonize mucus; Sci Rep., 3:1110; DOI: 10.1038/srep01110. Epub 2013 Jan 23




From The Lab To Industry...


SF7489 Biological Fungicide

Starting life as a food colouring candidate, this novel metabolite from a unique strain of Epiccocum purpurascens has excellent efficacy against a broad range of phytopathogenic filamentous fungi, and potential pharmaceutical uses. More >>>

Copyright © 2014 The Metabolomics Laboratory

The University of Auckland